Aptose Biosciences
APTO
#10584
Rank
NZ$7.42 M
Marketcap
NZ$2.91
Share price
0.00%
Change (1 day)
-41.88%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -NZ$34.7 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$42.92 Million, an increase over its 2023 earnings that were of -NZ$89.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$34.7 Million-19.17%
2024 -NZ$42.92 Million-51.82%
2023 -NZ$89.09 Million22.9%
2022 -NZ$72.5 Million-34.91%
2021 -NZ$0.12 Billion17.36%
2020 -NZ$94.9 Million107.65%
2019 -NZ$45.7 Million-7.73%
2018 -NZ$49.53 Million160.68%
2017 -NZ$19 Million-20.27%
2016 -NZ$23.84 Million28.71%
2015 -NZ$18.52 Million
2013 -NZ$10.5 Million
2010 -NZ$8.94 Million-8.31%
2009 -NZ$9.75 Million
2006 -NZ$18.08 Million-156.93%
2005 NZ$31.74 M-185.16%
2004 -NZ$37.28 Million458.58%
2003 -NZ$6.68 Million-63.66%
2002 -NZ$18.37 Million-8.04%
2001 -NZ$19.98 Million16.73%
2000 -NZ$17.11 Million294.99%
1999 -NZ$4.34 Million-6.51%
1998 -NZ$4.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-NZ$0.11 Billion 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-NZ$0.12 Billion 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-NZ$57.9 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA